Question 1

Has Rinki Mahay, MD received payments from drug or device companies?

Accepted Answer

Yes. Drug and device makers reported $238 in general payments to Rinki Mahay, MD across 13 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Question 2

Does a payment mean Rinki Mahay, MD did something wrong?

Accepted Answer

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Question 3

Where does this information about Rinki Mahay, MD come from?

Accepted Answer

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Company	Payments	Total
Takeda Pharmaceuticals U.S.A., Inc.	3	$44
Medtronic	2	$44
Trevena, Inc.	2	$36
Aimmune Therapeutics, Inc.	2	$36
Actelion Pharmaceuticals US, Inc.	1	$30
Amgen	1	$18
Pacira Pharmaceuticals Incorporated	1	$16
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC	1	$14

Rinki Mahay, MD

Payments from drug & device makers

Who reported the general payments

How this compares

Medicare billing

Other anesthesiology in Granite City